Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines
Clinical trial NCT02580370 · COMPLETED
Trial details
- NCT number
- NCT02580370
- Sponsor
- Revance Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-07-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.